Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Effect of apixaban, an oral and direct factor Xa inhibitor, on coagulation activity biomarkers following acute coronary syndrome.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Effect of apixaban, an oral and direct factor Xa inhibitor, on coagulation activity biomarkers following acute coronary syndrome.
Effect of apixaban, an oral and direct factor Xa inhibitor, on coagulation activity biomarkers following acute coronary syndrome. Thromb Haemost. 2010 Nov; 104(5):976-83.
View in:
PubMed
subject areas
Acute Coronary Syndrome
Administration, Oral
Adult
Aged
Aged, 80 and over
Biomarkers
Blood Coagulation
Chi-Square Distribution
Chromatography, Liquid
Dose-Response Relationship, Drug
Double-Blind Method
Down-Regulation
Enzyme-Linked Immunosorbent Assay
Factor Xa
Factor Xa Inhibitors
Female
Fibrin Fibrinogen Degradation Products
Fibrinolytic Agents
Humans
International Normalized Ratio
Male
Middle Aged
Odds Ratio
Partial Thromboplastin Time
Peptide Fragments
Placebo Effect
Prothrombin
Pyrazoles
Pyridones
Tandem Mass Spectrometry
Thrombin
Time Factors
Treatment Outcome
authors with profiles
Robert Harrington